C.M. Bidwell & Associates’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119 | Hold |
96
| – | – | ﹤0.01% | 443 |
|
|
2025
Q1 | $113 | Hold |
96
| – | – | ﹤0.01% | 436 |
|
|
2024
Q4 | $176 | Sell |
96
-220
| -70% | -$403 | ﹤0.01% | 479 |
|
|
2024
Q3 | $537 | Hold |
316
| – | – | ﹤0.01% | 461 |
|
|
2024
Q2 | $433 | Hold |
316
| – | – | ﹤0.01% | 449 |
|
|
2024
Q1 | $1.19K | Hold |
316
| – | – | ﹤0.01% | 418 |
|
|
2023
Q4 | $3.1K | Hold |
316
| – | – | ﹤0.01% | 385 |
|
|
2023
Q3 | $2.64K | Hold |
316
| – | – | ﹤0.01% | 427 |
|
|
2023
Q2 | $4.2K | Hold |
316
| – | – | ﹤0.01% | 407 |
|
|
2023
Q1 | $3.66K | Hold |
316
| – | – | ﹤0.01% | 410 |
|
|
2022
Q4 | $2.59K | Buy |
316
+220
| +229% | +$1.8K | ﹤0.01% | 417 |
|
|
2022
Q3 | $1K | Buy |
+96
| New | +$1K | ﹤0.01% | 459 |
|
|
2022
Q2 | – | Sell |
-96
| Closed | -$1K | – | 536 |
|
|
2022
Q1 | $1K | Buy |
+96
| New | +$1K | ﹤0.01% | 502 |
|